HiberCell to Present Pre-clinical Data on its Novel GCN2 Activator and PERK Inhibitor Programs at…
<!-- Name:DistributionId Value:8794695 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value: -->…
Browsing Tag
Activator
HiberCell to Present Preclinical Data from Novel GCN2 Activator and PERK Inhibitor Programs at The…
NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) -- HiberCell, a clinical-stage biotechnology company developing therapeutics to address therapeutic resistance, cancer relapse and metastasis, today announced two clinical abstract poster…
Spring Activator launches Health Impact Investor Challenge accelerating early-stage healthcare…
VANCOUVER, British Columbia, Nov. 30, 2021 (GLOBE NEWSWIRE) -- On a mission to accelerate investment in impact startups driving social and environmental change to make the world a better place, Spring Activator today announced the launch…